'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study'-author's reply

被引:2
|
作者
Lecomte, Raphael [1 ,2 ]
Deschanvres, Colin [1 ,2 ]
Coudol, Sandrine [3 ]
Wargny, Matthieu [3 ]
Camou, Fabrice [4 ]
Boutoille, David [1 ,2 ]
机构
[1] CHU Hotel Dieu, Dept Infect Dis, Nantes, France
[2] CHU Nantes, Ctr dInvest Clin, Unite dInvest Clin, INSERM 1413, Nantes, France
[3] Pole Hosp Univ 11 St Publ, CHU Nantes, Clin Donnees, Nantes, France
[4] CHU Bordeaux, Intens Care & Infect Dis Unit, Grp Saint Andre, Bordeaux, France
关键词
D O I
10.1016/j.cmi.2021.03.023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1180 / 1181
页数:2
相关论文
共 16 条
  • [1] Re: 'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study' by Lecomte et al.
    Buis, David Tijmen Paulus
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1179 - 1179
  • [2] Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study
    Lecomte, Raphael
    Bourreau, Alexis
    Deschanvres, Colin
    Issa, Nahema
    Le Turnier, Paul
    Gaborit, Benjamin
    Chauveau, Marie
    Leroy, Anne-Gaelle
    Le Tourneau, Thierry
    Caillon, Jocelyne
    Camou, Fabrice
    Boutoille, David
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (07) : 1015 - 1021
  • [3] Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review
    Loubet, P.
    Burdet, C.
    Vindrios, W.
    Grall, N.
    Wolff, M.
    Yazdanpanah, Y.
    Andremont, A.
    Duval, X.
    Lescure, F-X
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (02) : 125 - 132
  • [4] Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis
    John M. Allen
    Lolade Bakare
    Anthony M. Casapao
    Ken Klinker
    Lindsey M. Childs-Kean
    Ariel F. Pomputius
    Infectious Diseases and Therapy, 2019, 8 : 671 - 686
  • [5] Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis
    Allen, John M.
    Bakare, Lolade
    Casapao, Anthony M.
    Klinker, Ken
    Childs-Kean, Lindsey M.
    Pomputius, Ariel F.
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (04) : 671 - 686
  • [6] Comparative effectiveness of empirical antibiotic treatments in methicillin-susceptible Staphylococcus aureus infective endocarditis: A post hoc analysis of a prospective French cohort study
    Lecomte, Raphael
    Deschanvres, Colin
    Bourreau, Alexis
    d'Epenoux, Louise Ruffier
    Le Turnier, Paul
    Gaborit, Benjamin
    Chauveau, Marie
    Michel, Magali
    Le Tourneau, Thierry
    Bemer, Pascale
    Corvec, Stephane
    Boutoille, David
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 142
  • [7] Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea
    Lee, S.
    Song, K. -H.
    Jung, S. -I.
    Park, W. B.
    Lee, S. H.
    Kim, Y. -S.
    Kwak, Y. G.
    Kim, Y. K.
    Kiem, S. M.
    Kim, H. -I.
    Kim, E. S.
    Park, K. -H.
    Kim, N. J.
    Jang, H. -C.
    Kim, H. B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (02) : 152 - 158
  • [8] Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study
    Lefevre, B.
    Hoen, B.
    Goehringer, F.
    Sime, W. Ngueyon
    Aissa, N.
    Alauzet, C.
    Jeanmaire, E.
    Henard, S.
    Filippetti, L.
    Selton-Suty, C.
    Agrinier, N.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (12) : 2605 - 2616
  • [9] Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study
    B. Lefèvre
    B. Hoen
    F. Goehringer
    W. Ngueyon Sime
    N. Aissa
    C. Alauzet
    E. Jeanmaire
    S. Hénard
    L. Filippetti
    C. Selton-Suty
    N. Agrinier
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2605 - 2616
  • [10] Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia
    Yetmar, Zachary A.
    Khodadadi, Ryan B.
    Go, John Raymond
    Chesdachai, Supavit
    Abu Saleh, Omar M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (04) : 423 - 430